Sources
References used across the site
These are the main FDA, NIH, and FTC references used to build the site's public information pages. They do not replace medical or legal advice, but they are the backbone for the copy on the site.
DailyMed: Ozempic prescribing information
Primary label source for severe gastrointestinal adverse reactions, retinopathy language, and boxed-warning statements.
FDA label: Wegovy (semaglutide) injection
Primary label source for common adverse-reaction frequencies and language about severe gastrointestinal reactions and diabetic retinopathy complications.
NIDDK: Gastroparesis overview
NIH patient overview explaining delayed gastric emptying, symptoms, diagnosis, and treatment topics.
NIDDK: Symptoms & causes of gastroparesis
NIH reference for common symptoms such as nausea, vomiting, early satiety, bloating, and abdominal pain.
NIDDK: Eating, diet, & nutrition for gastroparesis
NIH guidance on smaller meals, low-fat and low-fiber foods, liquids, and hydration strategies when symptoms are active.
MedlinePlus: Semaglutide injection drug information
NIH drug reference for common side effects, serious warnings, and when patients should call a clinician.
NEI: Diabetic retinopathy
National Eye Institute overview of diabetic retinopathy, symptoms, risk of vision loss, and treatment basics.
NEI: Get a dilated eye exam
National Eye Institute guidance on dilated eye exams and why they matter even before symptoms are obvious.
FTC: Health Products Compliance Guidance
Federal Trade Commission guidance on keeping health-related claims truthful, qualified, and supported.